Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-25

Clinical Trial Update: Memantine Therapy in Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

This update notes the Phase 2 clinical trial evaluating memantine for amyotrophic lateral sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memantine (memantine)

Snippet

Sponsor: Phoenix Neurological Associates, LTD | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED